Mirtazapine Dosing for Appetite Stimulation
For appetite stimulation in adults, start mirtazapine at 7.5 mg at bedtime and titrate to a maximum of 30 mg at bedtime based on response and tolerability.
Dosing Regimen
Initial Dose
- Start with 7.5 mg at bedtime 1
- This lower-than-standard dose minimizes sedation while providing appetite-stimulating effects 2
- The FDA-approved starting dose for depression is 15 mg, but lower doses are commonly used off-label for appetite stimulation 3
Dose Titration
- Increase to 15 mg at bedtime if appetite response is inadequate after 1-2 weeks 1
- Maximum dose: 30 mg at bedtime for appetite stimulation 1
- Dose changes should not occur more frequently than every 1-2 weeks due to mirtazapine's 20-40 hour half-life 3
Timing
- Administer at bedtime to leverage sedating effects and minimize daytime impairment 1
- Steady-state plasma levels are achieved within 5 days 3
Mechanism and Clinical Effects
How It Works
- Mirtazapine blocks presynaptic alpha-2 adrenergic receptors and antagonizes 5-HT2 and 5-HT3 receptors 4
- This mechanism promotes sleep, appetite, and weight gain 1
- The appetite-stimulating effect is particularly pronounced at lower doses (7.5-15 mg) 2
Expected Response
- Appetite improvement may occur within 4-6 days of initiating therapy 5
- In cancer patients with anorexia, mirtazapine significantly increased energy intake by 379.3 kcal after 4 weeks, with particular increases in protein (22.5 g), carbohydrates (43.4 g), and fats (13.2 g) 6
- The NCCN guidelines specifically note mirtazapine may be especially effective in patients with depression and anorexia 1
Special Populations
Elderly Patients
- Start with 7.5 mg at bedtime 1
- Oral clearance is reduced by 40% in elderly males and 10% in elderly females compared to younger adults 3
- Females exhibit significantly longer elimination half-lives (37 hours) compared to males (26 hours) across all ages 3
Renal Impairment
- Reduce dose by approximately 30% in moderate renal impairment (CrCl 11-39 mL/min) 3
- Reduce dose by approximately 50% in severe renal impairment (CrCl <10 mL/min) 3
- Start with 7.5 mg and titrate cautiously 3
Hepatic Impairment
- Reduce initial dose by approximately 30% due to decreased oral clearance 3
- Start with 7.5 mg at bedtime and monitor closely 3
Adverse Effects and Monitoring
Common Side Effects
- Sedation is the most common adverse effect, particularly at higher doses 7, 4
- Increased appetite and weight gain are expected therapeutic effects when used for appetite stimulation 1, 7
- Dizziness may occur 7
- Nightmares were reported more frequently at 2 weeks in one trial but resolved by 4-8 weeks 6
Safety Considerations
- Mirtazapine is well tolerated with minimal cardiovascular and anticholinergic effects 4
- The American Heart Association notes mirtazapine is safe in cardiovascular disease and offers additional benefits including appetite stimulation 1
- Transient elevations in cholesterol and liver function tests may occur 7
Clinical Context
Primary Indications for Appetite Stimulation
- Cancer-related anorexia and cachexia 1, 6
- Alzheimer's disease and dementia with poor appetite 1
- Palliative care settings where appetite loss impacts quality of life 1
Advantages Over Alternatives
- Unlike corticosteroids and progestational agents (megestrol acetate, medroxyprogesterone), mirtazapine addresses both appetite loss and commonly comorbid depression/anxiety 1
- Provides additional benefit for insomnia, which frequently coexists with appetite loss 1
- Better side effect profile than traditional appetite stimulants in cardiovascular disease 1
Important Caveats
- Lower doses (7.5 mg) minimize sedation while maintaining appetite-stimulating effects, making this the preferred starting point 2
- The appetite-stimulating effect appears most robust for fat intake, which provides concentrated energy for malnourished patients 6
- While appetite scores may not always show statistical improvement, actual energy intake increases significantly 6
- Mirtazapine should be discontinued gradually over several weeks rather than abruptly to avoid withdrawal symptoms 3
- Allow at least 14 days between discontinuing an MAOI and starting mirtazapine, and vice versa 3